Fundraising Fox
Aardvark Therapeutics
NASDAQ: AARDSan Diego, US · Founded 2017 · Delaware corporation · 33 employees on LinkedIn · 5 known investors
Find your way into Aardvark Therapeutics
Sign up to see every warm intro you have to Aardvark Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aardvark Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs that inhibit hunger to treat metabolic diseases. Its lead compound, ARD-101, is an oral investigational drug for hunger-associated rare diseases that activates bitter taste receptors in the gut to trigger satiety signals, with potential applications in hyperphagia and obesity.
Founders & leadership
Aardvark Therapeutics was founded in 2017 by Tien Lee.
Board
Investors · 5
How we know: the company's own site · Decheng Capital's portfolio page · the S-1 prospectus · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
How we know: LG Technology Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$103.1M disclosed across 3 of 5 rounds · 1900–2024
▶$85MraisedMay 2024 · 31 investors · BiotechnologyRule 506(b)
- Jeffrey ChiDirector
- Victor TongDirector
- Nelson SunExecutive Officer
- Tien-Li LeeExecutive Officer, Director
- Offering amount
- $85M
- Amount sold
- $85M
- Sales commissions
- $1.7M
- Placement agents
- Cantor Fitzgerald & Co.
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.1MraisedJun 2021 · 8 investors · BiotechnologyRule 506(b)
- Zachary HornbyDirector
- Jerel BanksDirector
- Tien-Li LeeExecutive Officer, Director
- Jeffrey ChiDirector
- Henry JiDirector
- Bob ShinDirector
- Offering amount
- $30M
- Amount sold
- $9.1M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$9MraisedMay 2019 · 12 investors · BiotechnologyRule 506(b)
- Bob ShinDirector
- Tien-Li LeeExecutive Officer, Director
- Jeffrey ChiDirector
- Offering amount
- $15M
- Amount sold
- $9M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Founder mafia
2 people who came through Aardvark Therapeutics went on to found or lead other companies.
Related companies · 5
Companies working in the same space as Aardvark Therapeutics.
In the news
Frequently asked questions
- What does Aardvark Therapeutics do?
- Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs that inhibit hunger to treat metabolic diseases. Its lead compound, ARD-101, is an oral investigational drug for hunger-associated rare diseases that activates bitter taste receptors in the gut to trigger satiety signals, with potential applications in hyperphagia and obesity.
- Who founded Aardvark Therapeutics?
- Aardvark Therapeutics was founded by Tien Lee in 2017.
- Who are Aardvark Therapeutics's investors?
- Aardvark Therapeutics's investors include Decheng Capital, Vickers Venture Partners, LG Technology Ventures, Premier Partners, Felicis Ventures.
- How much funding has Aardvark Therapeutics raised?
- Aardvark Therapeutics has disclosed $103.1M raised across 3 of its 5 known rounds.
- Where is Aardvark Therapeutics headquartered?
- Aardvark Therapeutics is headquartered in San Diego, US.